[MYGN] YoY Quarter Result on 31-Mar-2018 [#Q1]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
09-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- -64.49%
YoY- 171.43%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
Revenue 173,100 164,000 216,600 193,500 196,900 190,500 179,985 -0.64%
PBT -49,600 -131,100 3,300 16,500 8,000 43,100 35,566 -
Tax -10,100 -15,900 -3,600 5,200 3,800 10,500 14,091 -
NP -39,500 -115,200 6,900 11,400 4,200 32,600 21,475 -
Tax Rate - - 109.09% -31.52% -47.50% -24.36% -39.62% -
Total Cost 212,600 279,200 209,700 182,100 192,700 157,900 158,510 5.01%
Ratio Analysis
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
NP Margin -22.82 -70.24 3.19 5.89 2.13 17.11 11.93 -
Per Share
31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 CAGR
EPS -0.52 -1.55 0.09 0.16 0.06 0.49 0.30 -
EPS Diluted -0.52 -1.55 0.09 0.16 0.06 0.47 0.29 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.